Client Result
OMERS GreenTech Invests in Redwood Materials
1 minute read | August.30.2023
Orrick represented OMERS GreenTech in its investment in Redwood Materials.
Search Results
Client Result
Eli Lilly to Acquire Versanis Bio in up to $1.925 Billion Deal With Potential Implications for Treating Obesity
2 minute read | July.20.2023
Eli Lilly and Company and Versanis Bio have announced a definitive agreement for Lilly to pay up to $1.925 billion in cash to acquire Versanis.
Client Result
DigitalOcean Acquires Paperspace for $111 Million to Expand AI Offerings
3 minute read | July.07.2023
DigitalOcean has acquired Paperspace, a cloud platform for building and scaling AI applications, for $111 million. Orrick advised Paperspace.
Client Result
Ten Million Domains: Squarespace to Acquire Google Domains Assets
2 minute read | June.22.2023
Squarespace Inc. has reached an agreement with Google to acquire assets associated with Google Domains.
Client Result
CIIG Capital Partners II, Inc. Completes Business Combination with Zapp
1 minute read | May.02.2023
CIIG Capital Partners II, Inc. has completed a combination with Zapp Electric Vehicles Ltd., a high-performance two-wheel electric vehicle company.
Client Result
Orrick Advises Catalyst Biosciences in Reverse Merger with GNI Group
1 minute read | December.28.2022
Orrick advised South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. in its acquisition of the F351 program, a ...
Client Result
Orrick Advises Kineta on Merger with Yumanity Therapeutics
June.06.2022
Under the definitive agreement, Kineta will become a wholly-owned subsidiary of Yumanity in an all-stock transaction.
Client Result
Orrick Advises Fisker on Launch of $350 Million At-the-Market Equity Program
May.24.2022
Orrick advised Fisker in connection with the establishment of its at-the-market equity program.
Client Result
Orrick Advised Catalyst Biosciences on $60 Million Sale of Complement Portfolio
May.24.2022
Orrick advised South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc.